North Idaho Urology

Coeur d'Alene, Idaho 83814

0 studies enrolling now · 20 studies all time

What they study most

Benign Prostatic Hypertrophy, Bladder Cancer, Enteric Hyperoxaluria, Fractures, Intermittent Urethral Catheterization, Interstitial Cystitis, Non-muscle Invasive Bladder Cancer (NMIBC), Osteoporosis, Overactive Bladder, Overactive Bladder With Urinary Incontinence, Prostate Cancer, Prostate Cancer Metastatic

Studies at this site

• A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) — Completed
• Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer — Stopped early
• Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer — Completed
• A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer — Completed
• BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC — Stopped early
• Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria — Completed
• Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer — Completed
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed
• Reuse of Intermittent Urethral Catheters — Completed
• PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer — Completed
• Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer — Stopped early
• Efficacy Study of ABR-215050 to Treat Prostate Cancer — Completed
• Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis — Stopped early
• Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
• R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence — Status unconfirmed
• Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy — Completed
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed